Zhejiang Tianrui Pharmaceutical Co. Ltd Sustainability Profile
Zhejiang Tianrui Pharmaceutical Co. Ltd., commonly referred to as Tianrui Pharma, is a prominent player in the pharmaceutical industry, headquartered in China. Established in 2001, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, primarily focusing on active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong operational presence across various regions in China and beyond, Tianrui Pharma is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of generic medications and specialty pharmaceuticals, distinguished by their adherence to stringent international standards. Tianrui Pharma has achieved notable recognition in the market, positioning itself as a trusted supplier in the global pharmaceutical landscape, thanks to its robust research and development capabilities and a dedication to enhancing healthcare outcomes.
DitchCarbon Score
How does Zhejiang Tianrui Pharmaceutical Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zhejiang Tianrui Pharmaceutical Co. Ltd's score of 20 is lower than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zhejiang Tianrui Pharmaceutical Co. Ltd's reported carbon emissions
Zhejiang Tianrui Pharmaceutical Co. Ltd, headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, there is no available information on their climate commitments or initiatives aimed at reducing carbon emissions. The company may be in the early stages of developing its sustainability strategy or may not have publicly disclosed its environmental impact data. In the broader context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction, often setting science-based targets to align with global climate goals. However, without specific data or commitments from Zhejiang Tianrui Pharmaceutical Co. Ltd, it is challenging to assess their position within this evolving landscape.
How Carbon Intensive is Zhejiang Tianrui Pharmaceutical Co. Ltd's Industry?
How Carbon Intensive is Zhejiang Tianrui Pharmaceutical Co. Ltd's Location?
Zhejiang Tianrui Pharmaceutical Co. Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Zhejiang Tianrui Pharmaceutical Co. Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
